A validated screening tool correctly identifies the majority of pregnant women at high risk of vitamin D deficiency

Clin Nutr ESPEN. 2022 Jun:49:301-306. doi: 10.1016/j.clnesp.2022.03.034. Epub 2022 Apr 6.

Abstract

Background & aim: The objective was to develop and validate a non-invasive screening tool to identify pregnant women at high risk of vitamin D deficiency.

Methods: Data from the Swedish prospective cohort GraviD, 2125 pregnant women, were randomly split in halves; one for developing the screening tool, and one for validation. Risk factors of vitamin D deficiency (serum 25-hydroxyvitamin D < 30 nmol/L) were identified using logistic regression analyses and odds ratios were translated into scores. Cutt offs to indicate high risk of vitamin D deficiency were evaluated by receiver operator characteristics.

Results: Five variables (season, clothing, eye color, fortified milk intake and vitamin D supplement use) were included in the screening tool. The possible total score was 0-42. Mean (95% CI) area under the curve for classification of vitamin D deficiency was 0.921 (0.893-0.948) (p < 0.001). A score of ≥15 points had 92% sensitivity and 76% specificity to identify women with 25OHD <30 nmol/L. This cut off had a positive predictive value of 31% and a negative predictive value of 99%.

Conclusion: This short non-invasive screening tool is valid as it correctly identified the majority of the vitamin D deficient pregnant women, who may benefit from further investigation for definite diagnosis and subsequent treatment.

Keywords: Malnutrition; Pregnancy; Screening tool; Vitamin D.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Calcifediol
  • Female
  • Humans
  • Pregnancy
  • Pregnant Women*
  • Prospective Studies
  • Vitamin D
  • Vitamin D Deficiency* / diagnosis

Substances

  • Vitamin D
  • Calcifediol